Summary of Mount Sinai's New York BCI Symposium, by Synchron and Precision Neuroscience. Market Trends and forecast for brain ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

Spinal cord compression—also called cervical spondylotic myelopathy (CSM)— is caused by any condition that puts pressure on the spinal cord. Symptoms may develop suddenly or gradually and may include ...

Spinal cord and dorsal root ganglion stimulation are established, safe treatments for chronic pain, but they carry a high explantation risk over a long-term period. The long-term explantation ...

Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Since the passing of ...

There's a new version of a spinal cord stimulator that is increasing the quality ... The stars aligned, as I was able to perform the second, third, fourth and fifth implants of this device in the ...

Current Board Chairman Jan Ohrstrom and Director Fred Colen to retire from the Board at year-end after 8 years of service EINDHOVEN, the Netherlands, Oct. 21, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N ...

Auto news: 'I wouldn't say never': Kia boss refuses to rule out ute adaption. © 2024 Nine Entertainment Co.

Since the passing of Professor Emeritus Alan Mackay-Sim AM in 2023, his ground-breaking legacy research is about to be realised with a Phase I human clinical trial commencing to test the efficacy and ...

[Photo courtesy of Pixium Vision] Onward Medical announced today that it appointed long-time Medtronic executive ... The Netherlands-based spinal cord stimulation technology developer plans ...

Australian researchers are about to launch a human trial to treat spinal cord injury by transplanting cells from the noses of paralysed patients into the damaged area. Griffith University ...